Jerry Williamson

Mr. Jerry Williamson leads Sengenics as CEO in preparing the company for significant growth. He has more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products. Prior to his most recent role as CEO and Board Director of NanoView Biosciences, Mr. Williamson was President, CEO and Board Director of Kew, Inc. and held senior positions at Metamark Genetics, Flagship Ventures, Molecular Devices (Danaher), Biacore (GE) and Pyrosequencing (QIAGEN). He earned his MBA from Boston University and BSc in Biochemistry from the University of Vermont.